Pharma Focus Europe

Ready to take your 3D cell culture workflows to the next level? Explore practical pipetting resources from Sartorius to help you prepare 3D cell cultures with confidence and consistency. 🔗 Explore the resources and optimize your workflow! sartorius.com/en/products/pi…

European pharma risk management is key to supply chain resilience, operational risk control and business continuity. Learn how pharma companies can strengthen drug supply security. pharmafocuseurope.com/articl… #Pharma #SupplyChain

𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲-𝐃𝐫𝐮𝐠 𝐂𝐨𝐧𝐣𝐮𝐠𝐚𝐭𝐞𝐬 are transforming cancer care in Europe! Discover how ADC innovations are advancing targeted therapies, improving survival outcomes and shaping the future of oncology. 🔗 pharmafocuseurope.com/articl… #ADC #Oncology

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

ADCs, peptides & advanced therapies are driving investment in specialised capabilities, sterile manufacturing and integrated pharma services. 🔗 pharmafocuseurope.com/articl… #CDMO #Pharmaceuticals

New exclusivity rules, comparative evidence incentives & faster assessments could reshape drug development and market access across Europe. 🔗 pharmafocuseurope.com/articl… #Pharma #DrugDevelopment

Advanced technologies, green chemistry & critical medicines policies are creating new opportunities for high-value API production and stronger pharma supply chains. 🔗 pharmafocuseurope.com/articl… #APIManufacturing #Pharmatwt

With ~100 biologics losing EU exclusivity by 2032, streamlined regulations and untapped markets are opening new doors for manufacturers. 🔗 pharmafocuseurope.com/articl… #Biosimilars #Pharmatwt

How can pharma companies succeed in Europe? Strategic pricing, market access planning, and informed investment decisions are key to navigating diverse healthcare systems and building sustainable growth. Read more: pharmafocuseurope.com/articl… #Pharma #MarketAccess

Sterile API manufacturing is evolving through closed processing, isolator technology, and digital monitoring. Discover how Annex 1, complex injectables, and supply resilience are shaping next-generation pharma production. Read more: pharmafocuseurope.com/articl… #Pharma #SterileAPI

Continuous manufacturing is reshaping pharma with potential cost savings, real-time quality control, and stronger supply resilience. How can strategic investments help European manufacturers stay competitive? Read more: pharmafocuseurope.com/articl… #Pharma #Manufacturing

How can digital innovation strengthen pharmaceutical R&D in Europe? AI, connected data, and smarter clinical trials offer opportunities to improve efficiency, reduce attrition, and accelerate drug development. Read more: pharmafocuseurope.com/articl… #Pharma #DigitalHealth

How do GMP systems and quality control shape pharmaceutical manufacturing in Europe? Discover how robust quality management supports compliance, product consistency and patient safety. 🔗 pharmafocuseurope.com/articl… #GMP #Pharma #QualityControl

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

From process development to GMP execution, effective handoffs can make a difference. Learn how biopharma teams can strengthen readiness and reduce challenges before clinical manufacturing begins. pharmafocuseurope.com/promot… #GMP #Biopharma #CDMO #DrugDevelopment

💊 October 2026 Pharma Industry Insights is here! Discover the latest pharma innovations, drug development trends, manufacturing advances & global market updates. Read the E-Newsletter: industry.pharmafocuseurope.c… #Pharma #PharmaNews

Gene therapy offers the promise of one-time, potentially curative treatments—but how do we monitor safety risks that may emerge years later? Discover why pharmacovigilance needs a new approach. 🔗pharmafocuseurope.com/articl… #GeneTherapy #DrugSafety

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

Regulatory approval is just the beginning. Explore how pharma companies can navigate Europe’s pricing, reimbursement, HTA requirements, and payer expectations to improve market access and patient reach. 🔗 pharmafocuseurope.com/articl… #MarketAccess #Pharma

Sanner Group combines 130+ years of patient-first expertise with pharmaceutical packaging and medical device capabilities, backed by global quality, local expertise and security of supply. Learn more: industry.pharmafocuseurope.c… #Pharma #Packaging #MedicalDevices